The Pharma & Biopharma Outsourcing Association (PBOA) today announced that Nelson Patterson, Vice President, Sales and Marketing at Baxter BioPharma Solutions, has been elected to its Board of Trustees, effective immediately. Mr. Patterson was elected after Baxter BioPharma Solutions joined the PBOA as a Sustaining Member.
Bristol-Myers Squibb has named its chief operation officer, Giovanni Caforio, as its new CEO. He...
U.S. employers advertised the most job openings in nearly 14 years in November, the Labor...
On January 1, 2015 the Life Science Industry lost one of its greatest and most distinguished leaders,Tom Tappen of Fluid Air, a division of Spraying Systems Co. Tom's dedication, passion and expertise in the pharmaceutical industry can never be replaced.
Endo International has announced changes to its executive leadership and senior management team. The changes are designed to support Endo's continued evolution into a leading global specialty healthcare company and accelerate growth both organically and through corporate development activities.
KaloBios Pharmaceuticals announced that David W. Pritchard, president and chief executive officer, has decided to retire, effective immediately, and has also resigned his position as a member of the company's Board of Directors.
Salix Pharmaceuticals has announced that Carolyn Logan has informed the Board of her decision to retire as President and Chief Executive Officer, and as a director, of the Company, effective January 30, 2015.
Sprout Pharmaceuticals today announced that Cindy Whitehead has been named CEO, effective immediately. Cindy co-founded Sprout Pharmaceuticals and previously served as president and chief operating officer.
Endo International announced today that Caroline B. Manogue, Executive Vice President, Chief Legal Officer has advised the company that she intends to retire from the company on July 1, 2015.
Cellceutix Corporation, a clinical stage biopharmaceutical company developing therapies with oncology, dermatology and antimicrobial applications, has announced that Daniel Jorgenson MD, MPH, MBA will join the Cellceutix team as Chief Medical Officer as of January 1, 2015.
United Therapeutics Corporation has announced two senior executive promotions as well as changes to Martine Rothblatt, Ph.D's compensation program.
Actavis has announced the planned senior management team that will lead the global pharmaceutical company following the successful close of the acquisition of Allergan anticipated in the second quarter of 2015.
Gilead Sciences has announced that Philippe C. Bishop, MD, will join the company as Senior Vice President, Hematology and Oncology Therapeutics. In this position, Dr. Bishop will report to John McHutchison, MD, Executive Vice President, Clinical Research.
Walgreens announced that Greg Wasson, president and chief executive officer, has informed the company’s board of directors that he will retire shortly after the close of the second step of the Alliance Boots transaction, on which shareholders are scheduled to vote on Dec. 29, 2014.
The Parenteral Drug Association (PDA) announced today the results of its 2014 Board of Directors election. PDA members voted for four volunteer directors over a period of three months this past fall.
ATS Labs is changing its company name to Accuratus Lab Services. ATS Labs recently completed a large acquisition of the assets of Microtest Laboratories enabling it to expand its service offering into the growing medical device and pharmaceutical market segments.
The facility recently completed the integration of staff into the state-of-the-art manufacturing suite and product development laboratories. The U.S. Operations Center will house 275 employees across management, administration, commercial operations, manufacturing and R&D, a set up designed to allow unique opportunities for collaboration across various operational disciplines.
GlaxoSmithKline released details of a restructuring program Wednesday, which included 900 layoffs.
Spark Therapeutics has announced today appointment of Daniel M. Takefman, Ph.D., as head of regulatory affairs. Dr. Takefman previously served as chief of the gene therapy branch of the Center for Biologics Evaluation and Research at the FDA, a position he held since 2006.
Zoetis today announced the appointment of Roman Trawicki as President of its Global Manufacturing and Supply organization.
Rigel Pharmaceuticals today announced James M. Gower is retiring from the board of directors and from his positions as chairman and chief executive officer, and Raul Rodriguez, most recently serving as the company's president and chief operating officer, will assume the position of chief executive officer and join the board of directors.
Shire has announced plans to relocate over 500 positions to Massachusetts from its Chesterbrook, Pennsylvania site and establish Lexington, Massachusetts as the company's U.S. operational headquarters. The transition is a continuation of the company's 'One Shire' efficiency program and will streamline business globally through two principal locations - Massachusetts and Switzerland.
Sanofi announced today that it has appointed Chief Scientific Officer Dr. Gary J. Nabel, M.D., Ph.D., as its Ebola response coordinator.
Purdue Pharma L.P. today announced that Gail Cawkwell, MD, PhD, former Vice President in the Medicines Development Group at Pfizer, has joined the company as Vice President of Medical Affairs.
The Department of Veterans Affairs has fired the director of the Pittsburgh VA Healthcare System a month after officials determined she committed unspecified "conduct unbecoming a senior executive" and wasteful spending.
Actavis has announced that Maria Teresa (Tessa) Hilado will join the company, effective December 8, 2014, as Chief Financial Officer. Ms. Hilado brings more than 26 years of global finance experience to the position, and will be based at the company's Parsippany, NJ, U.S. Administrative Headquarters.
Alexion Pharmaceuticals has named Senior Vice President Julie O'Neill to replace company co-founder Stephen Squinto when the executive vice president and chief global operations officer retires Jan. 1
Alfa Laval intends to consolidate the European manufacturing footprint of air heat exchangers for refrigeration applications to existing manufacturing sites in Italy, Poland and Finland. The intention is to close the site in Groningen, the Netherlands, by September 2015.
- Page 1